OppenheimerFunds Inc. grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 161.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 200,844 shares of the company’s stock after acquiring an additional 124,161 shares during the quarter. OppenheimerFunds Inc. owned about 0.34% of Molina Healthcare worth $15,400,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. First Quadrant L P CA lifted its stake in Molina Healthcare by 1,030.6% during the third quarter. First Quadrant L P CA now owns 3,618 shares of the company’s stock worth $249,000 after purchasing an additional 3,298 shares during the last quarter. Crossmark Global Holdings Inc. bought a new position in Molina Healthcare during the third quarter worth $586,000. Frontier Capital Management Co. LLC lifted its stake in Molina Healthcare by 55.7% during the third quarter. Frontier Capital Management Co. LLC now owns 178,323 shares of the company’s stock worth $12,261,000 after purchasing an additional 63,810 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Molina Healthcare by 2.8% during the third quarter. Principal Financial Group Inc. now owns 192,315 shares of the company’s stock worth $13,224,000 after purchasing an additional 5,181 shares during the last quarter. Finally, BNP Paribas Arbitrage SA lifted its stake in Molina Healthcare by 5.9% during the third quarter. BNP Paribas Arbitrage SA now owns 270,981 shares of the company’s stock worth $18,633,000 after purchasing an additional 15,180 shares during the last quarter. 96.22% of the stock is owned by hedge funds and other institutional investors.
In other Molina Healthcare news, insider William Dentino sold 67,500 shares of the business’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $86.71, for a total value of $5,852,925.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Steven J. Orlando sold 1,500 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $72.77, for a total value of $109,155.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 425,025 shares of company stock valued at $35,069,039. 6.20% of the stock is currently owned by corporate insiders.
Shares of Molina Healthcare, Inc. (NYSE MOH) traded down $0.05 during mid-day trading on Wednesday, reaching $76.09. The company had a trading volume of 668,959 shares, compared to its average volume of 1,288,930. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.13. The firm has a market cap of $4,527.90, a price-to-earnings ratio of -8.44, a price-to-earnings-growth ratio of 1.34 and a beta of 1.28. Molina Healthcare, Inc. has a twelve month low of $42.56 and a twelve month high of $93.98.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Monday, February 12th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.11. The company had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.96 billion. Molina Healthcare had a positive return on equity of 17.64% and a negative net margin of 2.58%. research analysts anticipate that Molina Healthcare, Inc. will post 3.68 EPS for the current year.
MOH has been the topic of a number of research analyst reports. ValuEngine raised Molina Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 8th. Leerink Swann increased their price target on Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, January 9th. BMO Capital Markets decreased their price target on Molina Healthcare from $98.00 to $85.00 and set a “market perform” rating for the company in a research report on Wednesday, February 14th. Morgan Stanley decreased their price objective on Molina Healthcare from $94.00 to $91.00 and set an “overweight” rating for the company in a research report on Wednesday, February 14th. Finally, Jefferies Group restated a “hold” rating and set a $80.00 price objective on shares of Molina Healthcare in a research report on Wednesday, February 14th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $73.73.
ILLEGAL ACTIVITY WARNING: This news story was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.thelincolnianonline.com/2018/03/14/oppenheimerfunds-inc-has-15-40-million-stake-in-molina-healthcare-inc-moh.html.
Molina Healthcare Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.